NEWS

Bharat Biotech gets emergency use authorisation for intranasal COVID-19 vaccine

Bharat Biotech International Ltd (BBIL) on Tuesday got emergency use authorisation from DCGI for intranasal COVID-19 vaccine, announced Union Health Minister Mansukh mandaviya.

This will be India’s first nasal vaccine for COVID

Source :
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top